Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024.
Moisan A, Regue H, Rahou Y, Gaymard A, Oblette A, Avon L, Bergaud N, Chalvignac R, Le Hingrat Q, Burrel S, Jary A, Colson P, Cappy P, Deroche L, Brodard V, Pronier C, Alessandri-Gradt E, Salmona M, Chollet L, Trémeaux P, Handala L, Fourati S, Lina B, Casalegno JS, Rameix-Welti MA, Josset L, Bal A; collaborative group; Bichat; Houhou N, Guilbaud R, Saint-Joannis T; Bordeaux; La Pitié-Salpêtrière; Marseille; Mondor; Reims; Rennes; Rouen; Saint-Louis; Toulon; Poggi C, Toyer AL, Domine M, Gardan V; Toulouse; Carcenac R, Demmou S, Latour J, Vellas C; Tours; Lyon; Pasteur; ANRS-MIE Technology working group. Moisan A, et al. Among authors: chollet l. Clin Microbiol Infect. 2024 Dec 24:S1198-743X(24)00605-0. doi: 10.1016/j.cmi.2024.12.018. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 39725080 No abstract available.
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study.
Fourati S, Reslan A, Bourret J, Casalegno JS, Rahou Y, Chollet L, Pillet S, Tremeaux P, Dossou NC, Gault E, Salmona M, Imbert-Marcille BM, Mirand A, Larrat S, Moisan A, Marot S, Schnuriger A, Veyrenche N, Engelmann I, Handala L, Henry A, Stephan V, Brichler S, Avettand-Fenoel V, Zemali N, Lefeuvre C, Pronier C, Deroche L, Jaffar-Bandjee MC, Mouna L, Francois C, Regueme A, Hartard C, Rogez S, Gallais F, Ly A, Rodriguez C, Dos Santos G, Simon-Loriere E, Schwartz O, Buchrieser J, Pawlotsky JM, Lemoine F, Audureau E, Rameix-Welti MA; POLYRES investigators. Fourati S, et al. Among authors: chollet l. Lancet Infect Dis. 2024 Oct 14:S1473-3099(24)00570-X. doi: 10.1016/S1473-3099(24)00570-X. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39419046
Faecalibacterium duncaniae as a novel next generation probiotic against influenza.
Chollet L, Heumel S, Deruyter L, Bouilloux F, Delval L, Robert V, Gevaert MH, Pichavant M, Sencio V, Robil C, Wolowczuk I, Sokol H, Auger S, Douablin A, Langella P, Chatel JM, Grangette C, Trottein F. Chollet L, et al. Front Immunol. 2024 Mar 12;15:1347676. doi: 10.3389/fimmu.2024.1347676. eCollection 2024. Front Immunol. 2024. PMID: 38590519 Free PMC article.
Epicardial adipose tissue dispersion at CT and recurrent atrial fibrillation after pulmonary vein isolation.
Huber AT, Fankhauser S, Wittmer S, Chollet L, Lam A, Maurhofer J, Madaffari A, Seiler J, Servatius H, Haeberlin A, Noti F, Brugger N, von Tengg-Kobligk H, Gräni C, Roten L, Tanner H, Reichlin T. Huber AT, et al. Among authors: chollet l. Eur Radiol. 2024 Aug;34(8):4928-4938. doi: 10.1007/s00330-023-10498-2. Epub 2024 Jan 10. Eur Radiol. 2024. PMID: 38197916 Free PMC article.
Rapid investigation of BA.4/BA.5 cases in France.
Kouamen AC, Da Cruz H, Hamidouche M, Lamy A, Lloyd A, Castro Alvarez J, Roussel M, Josset L, Enouf V, Felici C, Dos Santos G, Schaeffer J, Maisa A; Regional COVID-19 Investigation Group; Laboratory Group. Kouamen AC, et al. Front Public Health. 2022 Oct 10;10:1006631. doi: 10.3389/fpubh.2022.1006631. eCollection 2022. Front Public Health. 2022. PMID: 36311621 Free PMC article.
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
Piccini JP, Caso V, Connolly SJ, Fox KAA, Oldgren J, Jones WS, Gorog DA, Durdil V, Viethen T, Neumann C, Mundl H, Patel MR; PACIFIC-AF Investigators. Piccini JP, et al. Lancet. 2022 Apr 9;399(10333):1383-1390. doi: 10.1016/S0140-6736(22)00456-1. Epub 2022 Apr 3. Lancet. 2022. PMID: 35385695 Clinical Trial.
Technical and procedural comparison of two different cryoballoon ablation systems in patients with atrial fibrillation.
Knecht S, Sticherling C, Roten L, Badertscher P, Chollet L, Küffer T, Spies F, Madaffari A, Mühl A, Baldinger SH, Servatius H, Osswald S, Reichlin T, Kühne M. Knecht S, et al. Among authors: chollet l. J Interv Card Electrophysiol. 2022 Aug;64(2):409-416. doi: 10.1007/s10840-021-01035-6. Epub 2021 Jul 28. J Interv Card Electrophysiol. 2022. PMID: 34319493 Free PMC article.
28 results